JHS Svendgaard Laboratories Limited

NSEI:JHS Stock Report

Market Cap: ₹1.4b

JHS Svendgaard Laboratories Past Earnings Performance

Past criteria checks 0/6

JHS Svendgaard Laboratories's earnings have been declining at an average annual rate of -53.8%, while the Personal Products industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 10.2% per year.

Key information

-53.8%

Earnings growth rate

-50.1%

EPS growth rate

Personal Products Industry Growth7.9%
Revenue growth rate-10.2%
Return on equity-7.3%
Net Margin-12.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

JHS Svendgaard Laboratories Limited (NSE:JHS) Not Doing Enough For Some Investors As Its Shares Slump 33%

Mar 07
JHS Svendgaard Laboratories Limited (NSE:JHS) Not Doing Enough For Some Investors As Its Shares Slump 33%

JHS Svendgaard Laboratories Limited's (NSE:JHS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Jan 22
JHS Svendgaard Laboratories Limited's (NSE:JHS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

A Look At The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)

Aug 19
A Look At The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)

There Are Reasons To Feel Uneasy About JHS Svendgaard Laboratories' (NSE:JHS) Returns On Capital

Aug 04
There Are Reasons To Feel Uneasy About JHS Svendgaard Laboratories' (NSE:JHS) Returns On Capital

JHS Svendgaard Laboratories (NSE:JHS) Will Want To Turn Around Its Return Trends

Apr 09
JHS Svendgaard Laboratories (NSE:JHS) Will Want To Turn Around Its Return Trends

Estimating The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)

Dec 01
Estimating The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)

Here’s What’s Happening With Returns At JHS Svendgaard Laboratories (NSE:JHS)

Jun 25
Here’s What’s Happening With Returns At JHS Svendgaard Laboratories (NSE:JHS)

Revenue & Expenses Breakdown
Beta

How JHS Svendgaard Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:JHS Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23874-1111560
30 Sep 23939-1391590
30 Jun 23938-1441560
31 Mar 231,026-1551710
31 Dec 22899-991490
30 Sep 22854-821360
30 Jun 22860-771220
31 Mar 22872-411180
31 Dec 21927291260
30 Sep 21988281230
30 Jun 211,056351110
31 Mar 211,010121070
31 Dec 201,192-321560
30 Sep 201,290-271630
30 Jun 201,331-421740
31 Mar 201,416-201900
31 Dec 191,355-31780
30 Sep 191,382-151770
30 Jun 191,294-51340
31 Mar 191,269-71750
31 Dec 181,274231630
30 Sep 181,318401700
30 Jun 181,329671350
31 Mar 181,4062611480
31 Dec 171,3044191130
30 Sep 171,093411940
30 Jun 171,090407920
31 Mar 171,051219950
31 Dec 161,031-143950
30 Sep 161,059-175930
30 Jun 161,007-198890
31 Mar 161,001-216820
31 Dec 15959-1301150
30 Sep 15835-1491090
30 Jun 15696-1861060
31 Mar 15553-222650
31 Dec 14418-178940
30 Sep 14363-224960
30 Jun 14330-2701070
31 Mar 14353-2881290
31 Dec 13468-1761460
30 Sep 13506-1451530
30 Jun 13550-1521120

Quality Earnings: JHS is currently unprofitable.

Growing Profit Margin: JHS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: JHS is unprofitable, and losses have increased over the past 5 years at a rate of 53.8% per year.

Accelerating Growth: Unable to compare JHS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: JHS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.6%).


Return on Equity

High ROE: JHS has a negative Return on Equity (-7.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.